• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Ampio Pharmaceuticals appoints Gregory A. Gould CFO

Ampio Pharmaceuticals appoints Gregory A. Gould CFO

June 6, 2014
CenterWatch Staff

Ampio Pharmaceuticals has appointed Gregory A. Gould chief financial officer, treasurer and corporate secretary. Gould, a veteran of the pharmaceutical and life sciences industry, is joining the company effective June 10. Mark McGregor, the company's current chief financial officer, will retire from Ampio Pharmaceuticals following a transition period later this year.

Gould has over eighteen years of senior management experience at public pharmaceutical and life sciences companies, where he has demonstrated success leading accounting and finance organizations, inclusive of fundraising, licensing transactions and acquisitions.

Most recently, Gould was the interim president and chief executive officer and chief financial officer of SeraCare Life Sciences, in Milford, Mass. Previously, Gould was the chief financial officer of Atrix Laboratories, in Fort Collins, Colo. Gould held positions of increasing responsibility in finance and accounting at Colorado MedTech in Boulder, Colo., a publicly traded medical device design and manufacturing company.  Gould currently serves on the board of directors of CytoDyn, a publicly traded drug development company pursuing ant-viral agents for the treatment of HIV. 

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing